¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"time factor effect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • intraatrial conduction time
    ½É¹æ³»Àüµµ½Ã°£
  • kaolin clotting time
    Ä«¿Ã¸°ÀÀ°í½Ã°£
  • latent time
    Àẹ½Ã°£
  • lead time
    Á¶±â¹ß°ß±â°£
  • maximum phonation time
    ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
  • mean tidal time
    Æò±Õ¼øÈ¯½Ã°£
  • phonation time
    ¹ß¼ºÁö¼Ó½Ã°£
  • polymerizing time
    ÁßÇսð£
  • potential doubling time
    ÀáÀç¹è°¡½Ã°£
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • partial thromboplastin time
    ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • peak concentration time
    ÃÖ°í³óµµ½Ã°£
  • perception time
    Áö°¢½Ã°£
  • person-time incidence rate
    »ç¶÷±â°£¹ß»ý·ü
  • reaction time
    ¹ÝÀÀ½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • biologic effect
    »ý¹°ÇÐÀûÈ¿°ú
  • blow back effect
    µÞ¹Ù¶÷È¿°ú, ÈÄdzȿ°ú
  • bridle effect
    °í»ßÈ¿°ú, Á¦¾îÈ¿°ú
  • carrier effect
    ¿î¹Ýüȿ°ú
  • carry-over effect
    ÀÜÈ¿
  • cavitation effect
    °øµ¿È¿°ú
  • ceiling effect
    ÃÖ°íÈ¿°ú
  • clasp-knife effect
    Á¢´ÂĮȿ°ú
  • cohort effect
    ÄÚȣƮȿ°ú
  • combined effect
    º´¿ëÈ¿°ú
  • concentration effect
    ³óµµÈ¿°ú
  • cumulative effect
    ´©ÀûÈ¿°ú, ÃàÀûÈ¿°ú
  • curative effect
    Ä¡·áÈ¿°ú
  • cytopathic effect
    ¼¼Æ÷º´º¯È¿°ú
  • delayed effect
    Áö¿¬È¿°ú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • in-flow effect
    À¯ÀÔ È¿°ú
  • indifferent effect
    ¹«°ü¼º ÀÛ¿ë.
  • inhibitory effect
    ¾ïÁ¦È¿°ú(åäð¤ Íý).
  • inhibitory effect
    ¾ïÁ¦È¿°ú.
  • inotropic effect
    ¼öÃàÃËÁøÈ¿°ú.
  • phase shift effect
    À§»ó º¯À§ È¿°ú
  • photochemical effect
    ±¤È­ÇÐÈ¿°ú.
  • photoconductive effect
    ±¤ÀüµµÈ¿°ú.
  • photoelectric effect
    ±¤ÀüÈ¿°ú(ÎÃï³üùÍý).
  • photoelectric effect
    ±¤ÀüÈ¿°ú
  • physiological effect
    »ý¸®Àû È¿°ú.
  • piezoelectric effect
    ¾ÐÀü È¿°ú
  • piezoelectric effect
    ¾ÐÀüÈ¿°ú
  • placebo effect
    Çö󼼺¸È¿°ú, À§¾àÈ¿°ú(Ê£å·üùÍý).
  • placebo effect
    Çö󼼺¸È¿°ú, À§<°¡>¾àÈ¿°ú(Ê£å·üùÍý).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • mesomeric effect
    °ø¸íÈ¿°ú
  • misregistration effect
    ¿Àµî·Ï È¿°ú
  • mottled effect
    ¾ó·è¹«´Ì
  • muscarinic effect
    ¹«½ºÄ«¸°¼ºÈ¿°ú(¡­àõüùÍý).
  • muscarinic effect
    ¹«½ºÄ«¸°¾çÈ¿°ú (¡­åÆüùÍý).
  • myocardium,aging effect
    ³ëÈ­Çö»ó(ÖÕûùúÞßÚ)
  • nicotinic effect
    ´ÏÄÚÆ¾ÀÛ¿ë, ´ÏÄÚÆ¾È¿°ú.
  • nicotinic effect
    ´ÏÄÚÆ¾(¼º)È¿°ú.
  • nitrogen sparing effect
    Áú¼ÒÀý¾àÈ¿°ú.
  • nonstochastic effect
    ºñÈ®·ü·ÐÀûÈ¿°ú
  • oblique angle effect
    »ç°¢ È¿°ú
  • obliquity effect
    ±â¿ï±âÈ¿°ú
  • on (and) off effect
    (ÀÚ±Ø)°³½ÃÁ¾·áÈ¿ °ú(ô±Ø°³½ÃÁ¾¿äÈ¿°ú).
  • on (and) off effect
    (ÀÚ±Ø)°³½ÃÁ¾·áÈ¿°ú(ô§Ð½ËÒã·ðûèçüùÍý).
  • on effect
    (ÀÚ±Ø)°³½ÃÈ¿°ú(ô±Ø°³½ÃÈ¿°ú).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • antinuclear factor
    Ç×ÇÙÀÎÀÚ(ù÷ú·ì×í­)
  • antipellagra factor
    Ç×(ù÷)Æç¶ó±×¶ó ÀÎÀÚ(ì×í­)
  • antipeptic ulcer factor
    Ç×(ù÷)±Ë¾ç(Ï÷åË) ÀÎÀÚ(ì×í­)
  • antipernicious anemia factor
    Ç×(ù÷)¾Ç¼ººóÇ÷(äÂàõÞ¸úì) ÀÎÀÚ(ì×í­)
  • antiscorbutic factor
    Ç×±«Ç÷º´ÀÎÀÚ(ù÷ÎÕúìÜ»ì×í­)
  • antisigma factor
    Ç×(ù÷)½Ã±×¸¶ ÀÎÀÚ(ì×í­)
  • antispecificity factor
    Çׯ¯À̼º ÀÎÀÚ(ù÷÷åì¶àõì×í­)
  • antisterility factor
    Ç׺ÒÀÓ ÀÎÀÚ(ù÷ÝÕìõì×í­)
  • antitermination factor
    Ç×Á¾·á ÀÎÀÚ(ù÷ðûÖõì×í­)
  • antixerophthalmic factor
    Ç׾ȱ¸ °ÇÁ¶Áõ ÀÎÀÚ(ù÷äÑϹËëðÏñøì×í­)
  • Arrenius factor
    ¾Æ·¹´Ï¿ì½º ÀÎÀÚ(ì×í­)
  • asymmetry factor
    ºñ±¸»ó ÀÎÀÚ (ުϹßÒì×í­)
  • atrial natriuretic factor
    ½É¹æ(ãýÛ®) ³ªÆ®·ý¹è¼³ÀÎÀÚ(ÛÉàÜì×í­)
  • bacteriocin factor
    "¹ÚÅ׸®¿À½Å ÀÎÀÚ(ì×í­), »ì±ÕÀÎÀÚ(߯жì×í­)"
  • binding factor
    °áÇÕÀÎÀÚ(Ì¿ùêì×í­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
EPF early pregnancy factor; endocarditis parietalis fibroplastica; endothelial proliferating factor; est...
HF Hageman factor; haplotype frequency; hard filled [capsule]; hay fever; head of fetus; head forward; ...
IF idiopathic fibroplasia; idiopathic flushing; immersion foot; immunofluorescence; indirect fluorescen...
KAF conglutinogen-activating factor; killer-assisting factor; kinase activating factor
LEF leukokinesis-enhancing factor; lupus erythematosus factor; lymphoid-enhanced binding factor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
% MPE maximum possible effect
MAE movement after effect
NIE negative inotropic effect
ROESY nuclear Overhauser effect spectroscopy
PREE partial reinforcement extinction effect
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • radiation effect
    ¹æ»ç¼± È¿°ú
  • radio-frequency thermal effect
    °íÁÖÆÄ ¿­ È¿°ú
  • Raman effect
    ¶ó¸¸ È¿°ú
  • ration effect
    ¹æ»ç¼± È¿°ú
  • resonance effect
    °ø¸í È¿°ú
  • reverse piezoelectric effect
    ¿ª¾ÐÀü È¿°ú
  • RF antennae effect
    °íÁÖÆÄ ¾ÈÅ׳ª È¿°ú
  • second influencing effect
    ÀÌÂ÷ È¿°ú
  • sedative effect
    ÁøÁ¤ È¿°ú
  • sensory effect
    °¨°¢ È¿°ú
  • shearing effect
    Àü´Ü È¿°ú
  • shimmering effect : ÈíÀÎ ½Ã ÄÝ·¹½ºÅ×·ÑÀÌ °áÁ¤ÀÌ Æ÷ÇԵǾî ÀÖ´Â ¿¯Àº ¹Ð¤ »öÀÇ ¾×ü°¡ ³ª¿À¸ç ÀÌ ÄÝ·¹½ºÅ×·Ñ °áÁ¤Àº À¯¸®°ü¿¡ ³»¿ë¹°ÀÎ ¾×ü¸¦ ³Ö¾î ±¤¼± ¾Æ·¡¿¡¼­ ºñÃ纸¸é Ư¡ÀûÀÎ ºûÀ» ³»´Â Çö»ó.

    shimming

    º¸Á¤
  • sialogogic effect
    Ÿ¾× ºÐºñ ÃËÁø È¿°ú
  • side effect
    ºÎÀÛ¿ë
    »ç¿ëµÈ ¾àǰÀ̳ª ¾àÁ¦°¡ ¸ñÀû ÀÌ¿ÜÀÇ ´Ù¸¥ °á°ú, Áï ¹Ý´ë ÀÛ¿ëÀ¸·Î ¾à¹°¿¡ ´ëÇÑ À¯ÇØ ÀÛ¿ë, ƯÈ÷ ±× Åõ¿©·Î È¿´ÉÀ» Ãß±¸ÇÏ´Â °Í°ú ´Ù¸¥ Á¶Á÷À̳ª ±â°ü °èÅë¿¡ ¹ÌÄ¡´Â ÇØ·Î¿î ¿µÇâ°ú °°Àº °Í.
  • siphonage effect
    ½ÎÀÌÆù È¿°ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
cohort effect Variation in health status arising from different causal factors to which each birth cohort in a population is exposed as environment and society change.
(12 Dec 1998)
Wedensky effect A relatively long enhancing effect following application of a maximal shock or stimulus to a neuromuscular preparation during which a subthreshold stimulation, otherwise too small to evoke a response, will produce a response; a relatively prolonged lowered threshold of excitability following a maximal shock.
(05 Mar 2000)
placebo effect An effect usually, but not necessarily, beneficial that is attributable to an expectation that the regimen will have an effect, i.e., the effect is due to the power of suggestion.
(12 Dec 1998)
common ion effect <chemistry> The influence on an equilibrium by the presence of a substance which contains ions that participate in the equilibrium.
(09 Oct 1997)
compton effect <radiobiology> An attenuation process observed for x and gamma radiation in which an incident photon interacts with an orbital electron of an atom to produce a recoil electron and a scattered photon of energy less than the incident photon.
(16 Dec 1997)
concentration-effect curve <pharmacology> This is a graph produced to show the relationship between the exposure concentration of a drug or other foreign chemical and the magnitude of the graded effect that it produces.
(05 Jan 1998)
Wolff-Chaikoff effect Blocking of the organic binding of iodine and its incorporation into hormone caused by large doses of iodine; usually a transient effect, but in large doses in susceptible individuals it can be prolonged and cause iodine myxoedema.
Synonym: Wolff-Chaikoff effect.
(05 Mar 2000)
Cotton effect The positive and negative displacement from zero of the rotation of plane polarised monochromatic light and the change of monochromatic circularly polarised light into elliptically polarised light in the immediate vicinity of the absorption band of the substance through which the light passes.
See: optical rotatory dispersion, circular dichroism.
(05 Mar 2000)
Crabtree effect Inhibition of cellular respiration of isolated systems by high concentrations of glucose; a "reciprocal" of Pasteur's effect; due, in part, to the inhibition of hexokinase by elevated glucose-6-phosphate.
Compare: Pasteur's effect.
(05 Mar 2000)
position effect A change in the phenotypic expression of one or more genes due to a change in its physical location with respect to other genes; may result from change in chromosome structure or from crossing-over.
(05 Mar 2000)
cumulative effect The condition in which repeated administration of a drug may produce effect's that are more pronounced than those produced by the first dose.
Synonym: cumulative action.
(05 Mar 2000)
Cushing effect A rise in systemic blood pressure when the intracranial pressure acutely increases, usually in excess of 50% of the systolic arterial pressure.
Synonym: Cushing effect, Cushing response.
(05 Mar 2000)
Haldane effect The promotion of carbon dioxide dissociation by oxygenation of haemoglobin.
(05 Mar 2000)
hall effect <physics> Transverse electric field which develops in a conductor (as a result of the Lorentz Force acting on the charge carriers) when current is driven across a magnetic field.
(13 Nov 1997)
halo effect The effect (usually beneficial) that the manner, attention, and caring of a provider have on a patient during a medical encounter, regardless of what medical procedure or services the encounter involves, the influence upon an observation of the observer's perception of the characteristics of the individual observed (other than the characteristics under study) or the influence of the observer's recollection or knowledge of findings on a previous occasion.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • geological time
    ÁöÁú ¿¬´ë
  • gliding time
    =FLEXTIME
  • green time
    ¤¼;û½ÅÈ£ ½Ã°£´ë(ÀÏ·ÃÀÇ ½ÅÈ£°¡ ¸ðµÎ û»öÀÌ µÇ´Â ½Ã°£)
  • half time
    ¹ÝÀÏ ±Ù¹«;¹ÝÀϱÞ;(½ºÆ÷Ã÷)ÇÏÇÁ ŸÀÓ;Áß°£ ÈÞ½Ä
  • half time
    ¹ÝÀÏ ³ëµ¿;¹ÝÀϱÞ;Áß°£ ÈÞ½Ä
  • high time
    ÁÁÀº ¶§(½Ã±â);È£±â;Èï°Ü¿ï(À¯ÄèÇÑ)¶§
  • hold time
    (·ÎÄÏ,¹Ì»çÀÏ ¹ß»ç½ÃÀÇ ÃÊÀбâ,ÀÛ¾÷ µîÀÇ)ÀϽÃÀû Áß´Ü(´ë±â)
  • lap time
    ÇÑ ¹ÙÄû µµ´Â ½Ã°£;ÀÏÁֽð£
  • lead time
    ±âȹ¿¡¼­ »ý»ê±îÁöÀÇ ½Ã°£;¹ßÁÖ¿¡¼­ ¹è´Þ±îÁöÀÇ ½Ã°£;¹ßÁÖ¿¡¼­ ¹è´Þ±îÁöÀÇ ½Ã°£
  • local time
    Áö¹æ½Ã;ÇöÁö ½Ã°£
  • machine time
    (ÄÄÇ»ÅÍ µîÀÇ) ÃÑ ÀÛµ¿½Ã(°£);ÀÛµ¿ ¿¬½Ã°£
  • mean solar time
    Æò±Õ žç½Ã;Æò±Õ½Ã
  • monkey time
    ¼­¸Ó ŸÀÓ
  • mountain time
    »êÁö Ç¥ÁؽÃ
  • needle time
    (¿µ)(¹æ¼Û)·¹ÄÚµå À½¾Ç½Ã°£
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á